For FY2020, FY2021, FY2022, 6M2022 and 6M2023, we had net cash used in operating activities of RMB602.6 million, RMB680.7 million, RMB543.5 million, RMB115.1 million and RMB526.5 million, respectively, including R&D expenses, selling and marketing expenses, general and administrative expenses to develop and promote our new products and services.
Business · p. 370
As such, we expect to continue to have net cash outflows from operating activities in the near future. We anticipate that we will only become profitable when we can obtain sufficient purchase orders and expand our sales to take advantage of economies of scale.
In 2020, 2021 and 2022, we also recorded a net operating cash outflow of RMB23.8 million, RMB62.9 million and RMB65.6 million, respectively.
Summary · p. 20
With our improved profitability, we also expect our operating cash flow to improve concurrently.
Summary · p. 21
As of October 31, 2023, we had cash and cash equivalents of RMB57.6 million, current financial assets at FVTPL of RMB181.0 million and unutilized bank facilities of RMB650.0 million.
We recorded net operating cash outflows in 2021 and 2022, which were primarily attributable to our net losses for the respective year/period as well as significant increases in various working capital balances as our scale of operations grew, including trade and bills receivables, inventory and restricted cash, partially offset by significant increases in trade and bill payables.
We recorded negative operating cash flows for the six months ended 30 June 2022 and 30 June 2023, primarily due to the increase in our trade receivables.
Financial Information · p. 319
Due to the efforts of our finance department, the negative operating cash flows of approximately RMB26.6 million for the six months ended 30 June 2022 decreased significantly to RMB4.6 million for the six months ended 30 June 2023.
Financial Information · p. 319
We plan to improve our net operating cash outflow by (i) enhancing our internal credit risk management through the credit management system established by our Group, strictly adhering to our policy of dealing only with customers of appropriate creditworthiness and history, and carrying out regular internal reviews to ensure compliance with such policy to reduce our credit risk exposure; (ii) closely monitoring the settlement of receivables and the payment schedules of our customers, timely reminding them of due payments, taking active follow-up actions to collect outstanding trade receivables and recover any overdue debts, and routinely review our collection and recovery process; and (iii) further expand our business and market coverage to increase our profit from operating activities.
Although we recorded a net cash outflow used in operating activities of approximately RMB29.3 million for FY2022, we will adopt the following measures with a view to improving our cash flow from operating activities:
Financial Information · p. 407
Our net cash used in operating activities of approximately RMB29.3 million for FY2022 was primarily attributable to the increase in our trade receivables by approximately RMB75.6 million and the increase in deposits, prepayments and other receivables by approximately RMB15.9 million, which were partially offset by other working capital changes.
We had net cash used in operating activities for the years ended 31 December 2021 and 2022, which was primarily due to the increase in our finance lease receivables as a result of our overall business growth in our automobile retail and finance business.
Financial Information · p. 400
We may record net cash used in operating activities in the future, in which case our working capital may be limited and our financial results and results of operations may be materially and adversely affected.
Financial Information · p. 400
Our Directors confirm that, taking into consideration the facilities presently available, other working capital and the estimated net proceeds from the Global Offering, we have sufficient working capital for our present requirements and for at least the next 12 months commencing from the date of this prospectus.
For similar reasons, we incurred a net operating cash outflow of RMB31.9 million in 2020.
Summary · p. 18
Our operating cash flow also improved from a net operating cash outflow of RMB31.9 million in 2020 to a net operating cash inflow of RMB178.9 million in 2021.
Summary · p. 18
Nevertheless, our net cash generated from operating activities increased by 19.3% from RMB155.9 million for the six months ended June 30, 2022 to RMB186.0 million for the same period in 2023.
Despite our continuous growth in revenue and volume and our narrowing negative gross margin from 2020 to 2022, we incurred operating losses and net operating cash outflow, mainly due to (i) the gross loss incurred in our operations in China during the three years ended December 31, 2022 and (ii) to a much lesser extent, our cross-border and the New Markets businesses in 2022.
Business · p. 213
In addition, in view of our net cash outflow from operating activities during the Track Record Period, we plan to ensure our working capital sufficiency by leveraging the above-mentioned measures to narrow down our net loss and improve our profitability, which will also translate into improved net operating cash flows.
Summary · p. 22
We believe that potential external financing sources, including those to which we will gain access after the Global Offering, will provide additional funding to fuel our business operation and expansion until we achieve profitability and positive operating cash flow.
As project execution starts from the third quarter of the year and the user acceptance tests are carried out in the fourth quarter of the corresponding year, we normally record net cash outflow from operating activities during the first three quarters of the year.
Business · p. 198
For the four months ended 30 April 2022 and 2023, we had net cash outflow from operating activities of RMB24.4 million and RMB31.6 million, respectively.
Our net cash used in operating activities was RMB495.2 million in 2021.
Financial Information · p. 345
Taking into account the financial resources available to us including our cash and cash equivalents on hand, the available banking facilities and the estimated net proceeds from the Global Offering, our Directors are of the view that we have available sufficient working capital to meet our present requirements and for at least the next 12 months from the date of this prospectus.
We have recorded net cash used in operating activities of RMB452.9 million, RMB770.0 million, RMB779.6 million, RMB169.4 million and RMB461.2 million, in 2020, 2021, 2022 and in the three months ended March 31, 2022 and 2023, respectively, primarily due to the net loss recorded and increases in our trade receivables, mainly due to our business growth.
Summary · p. 19
To ensure working capital sufficiency, we plan to enhance our working capital management efficiency, improve our management of trade receivables and increase the focus on trade receivable collection.
We had negative cash flows from operations in 2019, 2021 and 2022, and positive cash flows in 2020 and the three months ended 31 March 2023.
Financial Information · p. 451
In addition, in view of our net cash outflow from operating activities in 2019, 2021 and 2022, we plan to ensure our working capital sufficiency by taking advantage of above-mentioned measures to narrow down our net loss and improve our profitability, which will in parallel translate into improved net operating cash flows.
Summary · p. 26
Further, as evidenced by our historical equity financing activities, we have a good track record in being able to raise money from renowned investors to finance our business.
Our net cash used in operating activities was RMB190.5 million, RMB238.7 million, and RMB79.2 million in 2021, 2022, and the four months ended April 30, 2023, respectively, primarily due to the significant research and development expenses and administrative expenses we incurred during the Track Record Period without generating any revenue from sales of our drug candidates.
Financial Information · p. 393
During the Track Record Period and up to the Latest Practicable Date, we have primarily funded our working capital requirements through proceeds from private equity financings.
We had negative cash flows from operations in 2019, 2020, 2021 and 2022. Our net cash used in operating activities was RMB277.0 million, RMB70.8 million, RMB868.5 million and RMB456.0 million, respectively, in 2019, 2020, 2021 and 2022.
Financial Information · p. 326
We will also enhance working capital management efficiency through continuously building a stable and collaborative relationship with our suppliers and customers and enhance credit management.
We recorded net cash used in operating activities of RMB485.9 million and RMB270.8 million for the years ended December 31, 2021 and 2022, respectively.
Financial Information · p. 526
Our primary uses of cash during the Track Record Period were to fund our research and development activities, the construction of our research and development and manufacturing facilities, and purchase of equipment, machinery and intangible assets.
Financial Information · p. 526
As of April 30, 2023, the latest practicable date for determining our indebtedness, we had cash and cash equivalents of RMB1,342.2 million.
During the Track Record Period, the Company was loss-making and expects to incur net losses and net operating cash outflow in the foreseeable future.
Summary · p. 7
Despite the net losses, cash outflow from operating activities, net liabilities and net current liabilities we recorded during the Track Record Period, we were able to maintain sufficient working capital, taking into account of the facts that: (i) our business growth and economies of scale achieved have led to narrowing adjusted net loss margin, a non-IFRS measure; (ii) both our net current liabilities and net liabilities situations were significantly affected by financial liabilities at fair value through profit and loss, which was not directly related to our operations or did not create any immediate contingency impact on our liquidity status; and (iii) the strong liquidity and capital resources we maintained during the Track Record Period.
Summary · p. 7
We will continue to enhance our fulfilment and delivery efficiency to our buyers so that we are able to collect payment on time. We will also continue to collect fees from our sellers on time to ensure a proper level of inflow of funds.
Net cash flows used in operating activities | (159,877) | (236,190)
Financial Information · p. 421
Our primary uses of cash are to fund the R&D activities of our Core Product and other product candidates, administrative expenses and other recurring expenses.
Financial Information · p. 421
Our Directors are of the opinion that, taking into account the financial resources available, including cash and cash equivalents, time deposits over three months and the estimated net proceeds from the Listing, as well as our cash burn rate, we have sufficient working capital to cover at least 125% of our costs, including selling and distribution expense, R&D costs, administrative expenses for at least the next 12 months from the date of this Prospectus.
We had net operating cash outflows during the Track Record Period primarily due to our proactive capital expenditure on purchase of devices to support our business growth.
Business · p. 198
For the year ended December 31, 2022, we managed to record a net cash inflow from operations of RMB595.5 million, which fully covered the procurement costs of devices during the same period.
Business · p. 195
Meanwhile, we seek to manage our cash flows by continuing increasing the portion of leased-in devices out of the total number of devices, thereby incurring less upfront capital expenditure.
During the Track Record Period, we primarily funded our working capital requirements through capital contributions from our shareholders and private equity financing.
Financial Information · p. 393
Our net cash used in operating activities was RMB19.2 million and RMB77.3 million in 2021 and 2022, respectively.
Financial Information · p. 393
As our business develops and expands, we expect to generate net cash from our operating activities through the sales revenue of our future commercialized products.